As part of our mission to broaden access to world-class education in drug development, the GMDP Academy is excited to announce a free public webinar pulled from our flagship Certification in Medicines Development (CMD) student program.

Whether you’re actively working in clinical research or simply passionate about innovation in drug development, this session offers timely insight into one of the most efficient and adaptive approaches to modern trial design: Platform Trials.

🗓️ Session Dates & Registration

Choose the date and time that fits your schedule:

🎓 About the Webinar

Platform Trials: Efficient Design for Evaluating Multiple Treatments

Platform trials are transforming the way we approach clinical research by allowing multiple therapies to be studied simultaneously under a unified protocol. In this session, we’ll explore the power and complexity of this design, along with examples of its real-world application in oncology and Covid-19.

Participants will walk away with a clearer understanding of how platform trials operate, when they are best used, and what makes them both promising and challenging.

🧠 Learning Objectives

By the end of the session, you will:

  • Understand what is meant by Master Protocols
  • Understand the design of Platform Trials
  • Appreciate the advantages and limitations of Platform Trials, in terms of methodology and practical aspects
  • Appreciate the practical use of Platform Trials through examples in oncology and Covid-19

🎤 Meet the Speaker: Dr. David Morgan

David Morgan gained degrees in Mathematics and in Applied Statistics from Oxford University. He had a thirty year career in the pharmaceutical industry, mostly within drug development, latterly with Ipsen Biopharm. His career included leadership of statistics and data management groups in UK and US and he spent 9 years in the CRO sector.

Since 2015 David has worked as a Statistical Consultant to the pharmaceutical industry and is also a Visiting Senior Lecturer within the Pharmaceutical Medicine Group at King’s College London. David has extensive experience in teaching statistics to non-statisticians, including 9 years early in his career lecturing at Cranfield University. In recent years he has taken part in training activities with industry professional bodies including TOPRA (Regulatory Affairs), ACDM (Data Management), the Faculty of Pharmaceutical Medicine and the Institute of Clinical Research, as well as with GMDP. He has also been an External Examiner at Kingston and Cardiff Universities.

David is a former chair and Honorary Life Member of PSI (Statisticians in the Pharmaceutical Industry). He also served as President of EFSPI (European Federation of Pharmaceutical Industry Statisticians) and as Editor-in-Chief of the Pharmaceutical Statistics Journal. He has authored or co-authored over 20 peer-reviewed journal articles including a series of “PSI Expert Group” publications in the Pharmaceutical Statistics Journal.

👥 Who Should Attend?

This session is ideal for:

  • Clinical researchers
  • Statisticians and data managers
  • Regulatory professionals
  • Medical and scientific staff
  • Anyone in drug development aiming to stay on the leading edge of trial design

📢 Don’t Miss Out

Seats are limited, and this is one of only a few CMD program sessions being made available to the public. If you’re invested in the future of efficient, adaptive trial design, this is a must-attend event.

Stay connected with GMDP Academy for more public sessions, expert insights, and global professional development opportunities in pharmaceutical medicine.

#PlatformTrials #ClinicalResearch #GMDPAcademy #CMDProgram #MasterProtocols #COVID19Research #MedicalInnovation #DrugDevelopment #FreeWebinar